Objective: Assess the efficacy of duloxetine 60/120 mg (N= 162) once daily compared with
placebo (N= 168) in the treatment of patients with fibromyalgia, during six months of …

Objectives: To evaluate the efficacy and safety of duloxetine 30 mg/d in adults with
fibromyalgia. Methods: This 12-week, randomized, double-blind, placebo-controlled study …

Objective: To investigate the efficacy of duloxetine in the treatment of pain and improvement
in functional impairment and quality of life in patients with fibromyalgia from a pooled …

Objectives Evaluate the efficacy and safety of duloxetine at doses up to 120 mg once daily in
patients with fibromyalgia. Methods This was a phase 3, 60-week study, which included an 8 …

The primary objectives of this study were to assess the efficacy and safety of duloxetine for
reducing pain severity in fibromyalgia patients with or without current major depressive …

OBJECTIVES: To assess the long-term safety, tolerability, and efficacy of duloxetine in
patients with fibromyalgia. METHODS: We report results from the 6-month extension phases …

Objectives To investigate whether comorbid major depressive disorder (MDD) influenced
the efficacy and safety of duloxetine in treating fibromyalgia (FM). Methods This was a post …

This was a 12-week, randomized, double-blind, placebo-controlled trial to assess the
efficacy and safety of duloxetine, a selective serotonin and norepinephrine reuptake …

Objective. To investigate the efficacy of flexible dose duloxetine 60–120 mg/day on changes
in fibromyalgia (FM) symptoms assessed by the Patient Global Impression of Improvement …

The purpose of this report is to describe the overall safety profile of both short-and longer-
term duloxetine treatment of fibromyalgia. Data from four double-blind, randomized, placebo …